Until joining the company a few years ago, J&J neuroscience R&D head Husseini Manji led the mood and anxiety disorders program at the National Institutes of Health.

Johnson & Johnson, the world's biggest maker of health-care products, anticipates submitting more than 10 new medicines for approval by regulators worldwide by 2017.

Johnson & Johnson (JNJ) unit Janssen Pharmaceutical Co. said it plans to submit more than 10 new product filings and more than 25 significant brand line extensions by 2017, which would amount to roughly the same number of new product filings it made in ...

In response to a staggering decline in sales and a recent U.S. Food and Drug Administration (FDA) proposal to tighten regulations on all-metal hip implants, Johnson & Johnson has opted to halt the sale of its metal-on-metal products. DePuy Orthopaedics ...

We have checkups for our bodies, our teeth, and even our cars. Why not do the same for our stocks? With that in mind, here is an inaugural monthly checkup for Johnson & Johnson (NYSE: JNJ ) stock. Let's look at three key areas to find out J&J's stock ...

(The follicularly-challenged central banker must truly be tearing his hair out right about now, for Rogaine maker Johnson & Johnson (JNJ) has just been assigned a �Sell� rating.) Thus in the space of one spacy session, investors learned the age-old ...

The panelists will include: Steve Bleiberg, Johnson & Johnson Technology manager in IT shared Services, Chris Bottger, IVCi Senior Vice President-Collaboration Services and Tim Reik, AVI-SPL Senior Vice President of Services Operations.

Today, we'll dive deeper into health care and consumer products giant Johnson & Johnson (NYSE: JNJ ) . Owning Johnson & Johnson stock as a dividend play makes all kinds of sense, because the company scores better than the Dow Jones Industrial ...

Shares of Johnson & Johnson (JNJ) have been in a solid uptrend throughout 2013. As shown in the chart below, the stock looks extended now, so investors should wait for a pullback.

Johnson & Johnson (NYSE:JNJ) is a giant in the medical field, with operations in the consumer products, medical devices, and pharmaceuticals arenas.